These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30421112)

  • 21. Developments in Cell-Penetrating Peptides as Antiviral Agents and as Vehicles for Delivery of Peptide Nucleic Acid Targeting Hepadnaviral Replication Pathway.
    Ndeboko B; Hantz O; Lemamy GJ; Cova L
    Biomolecules; 2018 Jul; 8(3):. PubMed ID: 30013006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiviral effect of oral administration of tenofovir disoproxil fumarate in woodchucks with chronic woodchuck hepatitis virus infection.
    Menne S; Cote PJ; Korba BE; Butler SD; George AL; Tochkov IA; Delaney WE; Xiong S; Gerin JL; Tennant BC
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2720-8. PubMed ID: 15980342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiviral effect of Phyllanthus nanus ethanolic extract against hepatitis B virus (HBV) by expression microarray analysis.
    Lam WY; Leung KT; Law PT; Lee SM; Chan HL; Fung KP; Ooi VE; Waye MM
    J Cell Biochem; 2006 Mar; 97(4):795-812. PubMed ID: 16237706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of duck hepatitis B virus replication by 2',3'-dideoxy-3'-fluoroguanosine in vitro and in vivo.
    Hafkemeyer P; Keppler-Hafkemeyer A; al Haya MA; von Janta-Lipinski M; Matthes E; Lehmann C; Offensperger WB; Offensperger S; Gerok W; Blum HE
    Antimicrob Agents Chemother; 1996 Mar; 40(3):792-4. PubMed ID: 8851615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of duck hepatitis B virus replication by purine 2',3'-dideoxynucleosides.
    Suzuki S; Lee B; Luo W; Tovell D; Robins MJ; Tyrrell DL
    Biochem Biophys Res Commun; 1988 Nov; 156(3):1144-51. PubMed ID: 3190693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitory activity of dioxolane purine analogs on wild-type and lamivudine-resistant mutants of hepadnaviruses.
    Seignères B; Pichoud C; Martin P; Furman P; Trépo C; Zoulim F
    Hepatology; 2002 Sep; 36(3):710-22. PubMed ID: 12198665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of a standardized cell culture assay to assess activities of nucleoside analogs against hepatitis B virus replication.
    Korba BE; Gerin JL
    Antiviral Res; 1992 Jul; 19(1):55-70. PubMed ID: 1444322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative activities of several nucleoside analogs against duck hepatitis B virus in vitro.
    Yokota T; Konno K; Chonan E; Mochizuki S; Kojima K; Shigeta S; de Clercq E
    Antimicrob Agents Chemother; 1990 Jul; 34(7):1326-30. PubMed ID: 2201250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pregenomic RNA Launch Hepatitis B Virus Replication System Facilitates the Mechanistic Study of Antiviral Agents and Drug-Resistant Variants on Covalently Closed Circular DNA Synthesis.
    Zhao Q; Chang J; Rijnbrand R; Lam AM; Sofia MJ; Cuconati A; Guo JT
    J Virol; 2022 Dec; 96(24):e0115022. PubMed ID: 36448800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measurement of Antiviral Effect and Innate Immune Response During Treatment of Primary Woodchuck Hepatocytes.
    Murreddu MG; Suresh M; Gudima SO; Menne S
    Methods Mol Biol; 2017; 1540():277-294. PubMed ID: 27975326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of chronic woodchuck hepatitis virus infection in the Eastern woodchuck (Marmota monax) with nucleoside analogues is predictive of therapy for chronic hepatitis B virus infection in humans.
    Korba BE; Cote P; Hornbuckle W; Tennant BC; Gerin JL
    Hepatology; 2000 May; 31(5):1165-75. PubMed ID: 10796894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of dominant negative mutants of the hepadnaviral core protein as antiviral agents.
    Scaglioni P; Melegari M; Takahashi M; Chowdhury JR; Wands J
    Hepatology; 1996 Nov; 24(5):1010-7. PubMed ID: 8903368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and in vitro antiviral activities of 3'-fluoro (or chloro) and 2',3'-difluoro 2',3'-dideoxynucleoside analogs against hepatitis B and C viruses.
    Srivastav NC; Shakya N; Mak M; Liang C; Tyrrell DL; Agrawal B; Kumar R
    Bioorg Med Chem; 2010 Nov; 18(21):7542-7. PubMed ID: 20869253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory effect of 9-(2-phosphonylmethoxyethyl)-adenine (PMEA) on human and duck hepatitis B virus infection.
    Heijtink RA; De Wilde GA; Kruining J; Berk L; Balzarini J; De Clercq E; Holy A; Schalm SW
    Antiviral Res; 1993 Jun; 21(2):141-53. PubMed ID: 8338351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of novel strategies to combat hepatitis B virus targetting wild-type and drug-resistant mutants in experimental models.
    Zoulim F
    Antivir Chem Chemother; 2001; 12 Suppl 1():131-42. PubMed ID: 11594680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro and in vivo anti-hepatitis B virus activities of a plant extract from Geranium carolinianum L.
    Li J; Huang H; Feng M; Zhou W; Shi X; Zhou P
    Antiviral Res; 2008 Aug; 79(2):114-20. PubMed ID: 18423640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitory effect of adefovir on viral DNA synthesis and covalently closed circular DNA formation in duck hepatitis B virus-infected hepatocytes in vivo and in vitro.
    Delmas J; Schorr O; Jamard C; Gibbs C; Trépo C; Hantz O; Zoulim F
    Antimicrob Agents Chemother; 2002 Feb; 46(2):425-33. PubMed ID: 11796353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of human hepatitis B virus replication by AT-61, a phenylpropenamide derivative, alone and in combination with (-)beta-L-2',3'-dideoxy-3'-thiacytidine.
    King RW; Ladner SK; Miller TJ; Zaifert K; Perni RB; Conway SC; Otto MJ
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3179-86. PubMed ID: 9835512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced antiviral benefit of combination therapy with lamivudine and famciclovir against WHV replication in chronic WHV carrier woodchucks.
    Korba BE; Cote P; Hornbuckle W; Schinazi R; Gerin JL; Tennant BC
    Antiviral Res; 2000 Jan; 45(1):19-32. PubMed ID: 10774587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Profound antiviral effect of oral administration of MIV-210 on chronic hepadnaviral infection in a woodchuck model of hepatitis B.
    Michalak TI; Zhang H; Churchill ND; Larsson T; Johansson NG; Oberg B
    Antimicrob Agents Chemother; 2009 Sep; 53(9):3803-14. PubMed ID: 19564357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.